Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07047989 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NWRD09 for HPV-16 Related Cervical HSIL

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 2, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is a single-arm, open label, multi-center clinical study to evaluate the safety, tolerability and immunogenicity HPV16 targeted mRNA therapeutic vaccine (NWRD09) in HPV16 related cervical high-grade squamous intraepithelial lesions (HSlL).
Trial Details
NCT Number NCT07047989
Lead Sponsor Newish Biotech (Wuxi) Co., Ltd.
Conditions
(from sponsor)		 High-grade Squamous Intraepithelial Lesion (HSIL)
Related terms Squamous Intraepithelial Lesions
Enrollment 9 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov